RO5310074

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5310074, covering 2016-10-27 to 2016-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5310074 in Patients With Psoriatic Arthritis [Phase 1]